• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

1例新型冠状病毒肺炎患者合并糖尿病酮症酸中毒和高渗高血糖状态

A Case of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State in a Patient With COVID-19.

作者信息

Rafique Shemitha, Ahmed Fahad W

机构信息

Diabetes and Endocrinology, Brighton and Sussex University Hospital, Brighton, GBR.

Diabetes and Endocrinology, Brighton and Sussex County Hospital, Brighton, GBR.

出版信息

Cureus. 2020 Jul 2;12(7):e8965. doi: 10.7759/cureus.8965.

DOI:10.7759/cureus.8965
PMID:32766007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7398733/
Abstract

The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2). Diabetes mellitus (DM) is one of the risk factors associated with severe illness in COVID-19 leading to increased hospital admissions and mortality. COVID-19 can precipitate hyperglycemic emergencies like diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) in patients with DM. We present a case of a patient with COVID-19 admitted to the hospital with combined DKA and HHS. The case highlights the challenge of managing patients with DM suffering from COVID-19.

摘要

2019年新型冠状病毒病（COVID-19）由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起。糖尿病（DM）是与COVID-19重症相关的危险因素之一，会导致住院人数和死亡率增加。COVID-19可促使糖尿病患者发生糖尿病酮症酸中毒（DKA）和高渗高血糖状态（HHS）等高血糖急症。我们报告一例因合并DKA和HHS入院的COVID-19患者。该病例凸显了管理患有COVID-19的糖尿病患者所面临的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/7398733/673a08c33c4f/cureus-0012-00000008965-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/7398733/55a08a8965e1/cureus-0012-00000008965-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/7398733/673a08c33c4f/cureus-0012-00000008965-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/7398733/55a08a8965e1/cureus-0012-00000008965-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/7398733/673a08c33c4f/cureus-0012-00000008965-i02.jpg

相似文献

1
A Case of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State in a Patient With COVID-19.1例新型冠状病毒肺炎患者合并糖尿病酮症酸中毒和高渗高血糖状态
Cureus. 2020 Jul 2;12(7):e8965. doi: 10.7759/cureus.8965.
2
Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series.与 COVID-19 相关的合并糖尿病酮症酸中毒和高渗高血糖状态患者的临床特征和结局：一项回顾性、基于医院的观察性病例系列研究。
Diabetes Res Clin Pract. 2020 Aug;166:108279. doi: 10.1016/j.diabres.2020.108279. Epub 2020 Jun 25.
3
Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies.年龄对酸中毒和高渗性糖尿病急症的表现及预后的影响。
Intern Med J. 2002 Aug;32(8):379-85. doi: 10.1046/j.1445-5994.2002.00255.x.
4
COVID-19 and Combined Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Nonketotic Coma: Report of 11 Cases.COVID-19 合并糖尿病酮症酸中毒及高血糖高渗非酮症昏迷：11 例报告。
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211021231. doi: 10.1177/23247096211021231.
5
Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year period.2型糖尿病合并糖尿病酮症酸中毒和高血糖高渗状态住院患者的临床特征、结局及危险因素：一项为期6年的基于医院的分析
BMC Endocr Disord. 2020 Dec 14;20(1):182. doi: 10.1186/s12902-020-00659-5.
6
COVID-19 and emergencies in patients with diabetes: two case reports.2型糖尿病患者的新型冠状病毒肺炎及紧急情况：两例病例报告
J Med Case Rep. 2021 Feb 2;15(1):57. doi: 10.1186/s13256-020-02659-4.
7
COVID-19 Related Predisposition to Diabetic Ketoacidosis.COVID-19相关的糖尿病酮症酸中毒易感性。
Cureus. 2023 Mar 25;15(3):e36674. doi: 10.7759/cureus.36674. eCollection 2023 Mar.
8
Combined diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 1 diabetes mellitus induced by immune checkpoint inhibitors: Underrecognized and underreported emergency in ICIs-DM.免疫检查点抑制剂诱导的 1 型糖尿病合并糖尿病酮症酸中毒和高渗高血糖综合征：ICI-DM 中的未被充分认识和报告的紧急情况。
Front Endocrinol (Lausanne). 2023 Jan 4;13:1084441. doi: 10.3389/fendo.2022.1084441. eCollection 2022.
9
A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID-19.一项英国全国性研究，纳入因糖尿病酮症酸中毒或高渗高血糖状态和 COVID-19 住院的成年人。
Diabetes Obes Metab. 2023 Jul;25(7):2012-2022. doi: 10.1111/dom.15076. Epub 2023 Apr 25.
10
Recognizing Complications in Youth With Diabetes Admitted With Diabetic Ketoacidosis Versus Hyperglycemic Hyperosmolar State.识别因糖尿病酮症酸中毒和高血糖高渗状态入院的青少年患者的并发症。
J Pediatr Health Care. 2024 Sep-Oct;38(5):761-768. doi: 10.1016/j.pedhc.2023.12.012. Epub 2024 Jun 18.

引用本文的文献

1
Combined Hyperglycemic Hyperosmolar Syndrome and Diabetic Ketoacidosis Associated with COVID-19 in a Pediatric Patient.一名儿科患者中与新冠病毒感染相关的高血糖高渗综合征合并糖尿病酮症酸中毒
Case Rep Crit Care. 2021 Nov 27;2021:6429710. doi: 10.1155/2021/6429710. eCollection 2021.
2
Hyperosmolar hyperglycemic state in children: case report and review of the literature.儿童高渗高血糖状态：病例报告及文献综述
J Klin Endokrinol Stoffwechs. 2022;15(2):60-62. doi: 10.1007/s41969-022-00164-1. Epub 2022 May 31.
3
Chest radiological finding of COVID-19 in patients with and without diabetes mellitus: Differences in imaging finding.

本文引用的文献

1
New-Onset Diabetes in Covid-19.新冠病毒感染引发的新发糖尿病
N Engl J Med. 2020 Aug 20;383(8):789-790. doi: 10.1056/NEJMc2018688. Epub 2020 Jun 12.
2
Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19.糖尿病对新冠病毒感染患者临床结局的影响。
Cardiovasc Diabetol. 2020 Jun 11;19(1):76. doi: 10.1186/s12933-020-01047-y.
3
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.美国住院新冠病毒疾病（COVID-19）患者的血糖特征及临床结局
患有和未患有糖尿病的COVID-19患者的胸部放射学表现：影像学表现的差异。
World J Radiol. 2022 Jan 28;14(1):13-18. doi: 10.4329/wjr.v14.i1.13.
4
Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia.2019冠状病毒病肺炎患者的既往糖尿病与新冠病毒相关高血糖症
Biology (Basel). 2021 Aug 5;10(8):754. doi: 10.3390/biology10080754.
5
A Retrospective Study Assessing the Effect of Diabetes on Mortality in Patients With COVID-19 at a Teaching Hospital in the United Kingdom.一项评估糖尿病对英国一家教学医院中新冠病毒肺炎患者死亡率影响的回顾性研究。
Cureus. 2021 Mar 15;13(3):e13902. doi: 10.7759/cureus.13902.
6
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells.SARS-CoV-2 细胞进入因子 ACE2 和 TMPRSS2 表达于人类胰腺的微血管和导管中，但在β细胞中并不丰富。
Cell Metab. 2020 Dec 1;32(6):1028-1040.e4. doi: 10.1016/j.cmet.2020.11.006. Epub 2020 Nov 13.
J Diabetes Sci Technol. 2020 Jul;14(4):813-821. doi: 10.1177/1932296820924469. Epub 2020 May 9.
4
Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports.伴有新型冠状病毒肺炎的急性高血糖危象：病例报告。
Diabetes Metab J. 2020 Apr;44(2):349-353. doi: 10.4093/dmj.2020.0091.
5
Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus.一名新诊断为糖尿病的患者因新冠病毒感染诱发糖尿病酮症酸中毒。
Diabetes Res Clin Pract. 2020 Jun;164:108166. doi: 10.1016/j.diabres.2020.108166. Epub 2020 Apr 24.
6
Practical recommendations for the management of diabetes in patients with COVID-19.关于 COVID-19 患者糖尿病管理的实用建议。
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550. doi: 10.1016/S2213-8587(20)30152-2. Epub 2020 Apr 23.
7
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
8
COVID-19 infection may cause ketosis and ketoacidosis.COVID-19 感染可能导致酮症和酮酸中毒。
Diabetes Obes Metab. 2020 Oct;22(10):1935-1941. doi: 10.1111/dom.14057. Epub 2020 May 18.
9
Tocilizumab treatment in COVID-19: A single center experience.托珠单抗治疗 COVID-19：单中心经验。
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
10
Endocrine and metabolic link to coronavirus infection.内分泌和代谢与冠状病毒感染的关联。
Nat Rev Endocrinol. 2020 Jun;16(6):297-298. doi: 10.1038/s41574-020-0353-9.